Article Details
Retrieved on: 2021-04-19 17:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In a report released today, Matthew Harrison from Morgan Stanley maintained a Buy rating on AlloVir (ALVR), with a price target of $50.00.
Article found on: www.smarteranalyst.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here